Overall, these in vivo results indicate that micro/nano-scale surface modifications can partially mitigate the vascular inhibitory effects of ZOL, thereby contributing to a favorable trend toward improved early osseointegration.
← all excerpts
Micro/nano-structured titanium surfaces promote endothelial responses and angiogenic activity under zoledronic acid exposure.
1
—
—